Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6468)
All Articles published online
|
Oct 31, 2009 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun L, Guan YS, Pan WM, Luo ZM, Wei JH, Zhao L, Wu H. Metabolic restaging of hepatocellular carcinoma using whole-body 18F-FDG PET/CT. World J Hepatol 2009; 1(1): 90-97 [PMID: 21160970 DOI: 10.4254/wjh.v1.i1.90] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v1/i1/90.htm |
| Number | Citing Articles |
| 1 |
Chun-Yi Lin, Jin-Hua Chen, Ji-An Liang, Cheng-Chieh Lin, Long-Bin Jeng, Chia-Hung Kao. 18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: A systematic review and meta-analysis. European Journal of Radiology 2012; 81(9): 2417 doi: 10.1016/j.ejrad.2011.08.004
|
| 2 |
Nobuyuki Hayakawa, Yuji Nakamoto, Koya Nakatani, Etsuro Hatano, Satoru Seo, Tatsuya Higashi, Tsuneo Saga, Shinji Uemoto, Kaori Togashi. Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients. International Journal of Clinical Oncology 2014; 19(6): 1020 doi: 10.1007/s10147-013-0653-3
|
| 3 |
Abdelhamid H. Elgazzar. Synopsis of Pathophysiology in Nuclear Medicine. 2014; : 191 doi: 10.1007/978-3-319-03458-4_9
|
| 4 |
Raluca Mititelu, Alexandru Mitoi, Catalin Mazilu, Mariana Jinga, Florentina Ionita Radu, Ana Bucurica, Teodora Mititelu, Sandica Bucurica. Advancements in hepatocellular carcinoma management: the role of 18F-FDG PET-CT in diagnosing portal vein tumor thrombosis. Nuclear Medicine Communications 2024; 45(8): 651 doi: 10.1097/MNM.0000000000001863
|
| 5 |
E. Edmund Kim, Hyung-Jun Im, Dong Soo Lee, Keon Wook Kang. Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT. 2016; : 199 doi: 10.1007/978-3-319-28652-5_2
|
| 6 |
Tamer Özülker, Filiz Özülker. Atlas of PET-CT Imaging in Oncology. 2015; : 311 doi: 10.1007/978-3-319-18994-9_10
|
| 7 |
Christian Buchbender, Till A. Heusner, Thomas C. Lauenstein, Andreas Bockisch, Gerald Antoch. Oncologic PET/MRI, Part 1: Tumors of the Brain, Head and Neck, Chest, Abdomen, and Pelvis. Journal of Nuclear Medicine 2012; 53(6): 928 doi: 10.2967/jnumed.112.105338
|
| 8 |
Ekhlas Abdelmonem Ibrahem Nasr Shaban. Can fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography detect hepatocellular carcinoma and its extrahepatic metastases?. The Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(1): 196 doi: 10.1016/j.ejrnm.2017.10.014
|
| 9 |
Xiaoli Liao, Junbao Wei, Yongqiang Li, Jianhong Zhong, Zhihui Liu, Sina Liao, Qian Li, Changyuan Wei. 18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma. Medicine 2018; 97(34): e11970 doi: 10.1097/MD.0000000000011970
|
| 10 |
Susan Adil Ali, Darine Helmy Amin, Yasser Ibrahim Abdelkhalek. Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients. Japanese Journal of Radiology 2020; 38(5): 472 doi: 10.1007/s11604-020-00930-8
|
| 11 |
Sung Hoon Kim, Kyoung Sook Won, Byung Wook Choi, Il Jo, Seok Kil Zeon, Woo Jin Chung, Jung Hyeok Kwon. Usefulness of F-18 FDG PET/CT in the Evaluation of Early Treatment Response After Interventional Therapy for Hepatocellular Carcinoma. Nuclear Medicine and Molecular Imaging 2012; 46(2): 102 doi: 10.1007/s13139-012-0138-8
|
| 12 |
Anna Maria De Gaetano, Vittoria Rufini, Paola Castaldi, Anna Maria Gatto, Laura Filograna, Alessandro Giordano, Lorenzo Bonomo. Clinical applications of 18F-FDG PET in the management of hepatobiliary and pancreatic tumors. Abdominal Imaging 2012; 37(6): 983 doi: 10.1007/s00261-012-9845-y
|
| 13 |
Jean-Noël Talbot, Laure Michaud, Jean-Didier Grange, Olivier Rosmorduc, Sona Balogova. Use of choline PET for studying hepatocellular carcinoma. Clinical and Translational Imaging 2014; 2(2): 103 doi: 10.1007/s40336-014-0055-1
|
| 14 |
Samar Ramzy Ragheb, Amr Mahmoud Ahmed Abelsamad, Moustafa Mahmoud Abelkawy, Osama Abu Elnaga Khalaf Nasr. Role of PET/CT in patients with unexplained rising alpha fetoprotein post HCC interventional management. Egyptian Journal of Radiology and Nuclear Medicine 2020; 51(1) doi: 10.1186/s43055-020-00158-6
|
| 15 |
Hyo Jung Seo, Yun Jung Choi, Hyun Jeong Kim, Yong Hyu Jeong, Arthur Cho, Jae Hoon Lee, Mijin Yun, Hye Jin Choi, Jong Doo Lee, Won Jun Kang. Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using 18F-FDG PET/CT and 99mTc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation. Nuclear Medicine and Molecular Imaging 2011; 45(3): 203 doi: 10.1007/s13139-011-0099-3
|
| 16 |
Swati Rachh, Sandip Basu. PET/CT in patients with liver lesions of different nature. Clinical and Translational Imaging 2014; 2(2): 139 doi: 10.1007/s40336-014-0061-3
|
| 17 |
Benedikt M. Schaarschmidt, Lino M. Sawicki, Gerald Antoch, Philipp Heusch. PET/MR Imaging: Current and Emerging Applications. 2018; : 23 doi: 10.1007/978-3-319-69641-6_3
|
| 18 |
Ilaria Grassi, Joshua James Morigi, Cristina Nanni, Stefano Fanti. FDG and other radiopharmaceuticals in the evaluation of liver lesions. Clinical and Translational Imaging 2014; 2(2): 115 doi: 10.1007/s40336-014-0059-x
|
| 19 |
Pablo R. Ros, Sukru Mehmet Erturk. Textbook of Gastrointestinal Radiology, 2-Volume Set. 2015; : 1561 doi: 10.1016/B978-1-4557-5117-4.00087-8
|
| 20 |
Binu V. John, Sean Aubuchon, Bassam Dahman, Venkata Rajesh Konjeti, Douglas Heuman, Jennifer Hubert, Smitha Thomas, Yangyang Deng, Cynthia Solomon, Latha Thankam Sundaram, Eleanor Love, Amit G. Singal, James L. Tatum. Addition of [18F]Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography to Cross‐Sectional Imaging Improves Staging and Alters Management in Hepatocellular Carcinoma. Liver Transplantation 2020; 26(6): 774 doi: 10.1002/lt.25743
|